Menu
ÚHKT

Impaktované publikace

[61]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

[62]

de Swart, L.; Smith, A.; MacKenzie, M.; Symeonidis, A.; Neukirchen, J.; Mikulenková, D.; Vallespi, T.; Zini, G.; Paszkowska-Kowalewska, M.; Kruger, A.; Saft, L.; Fenaux, P.; Bowen, D.; Hellström-Lindberg, E.; Čermák, J.; Stauder, R.; Tatic, A.; Holm, M.S.; Malcovati, L.; Madry, K.; Droste, J.; Blijlevens, N.; de Witte, T.; Germing, U.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

[rok vydání 2017, impact factor 2.845 ]

[63]

Brezinova, J.; Zemanova, Z.; Bystricka, D.; Sarova, I.; Lizcova, L.; Malinova, E.; Izakova, S.; Sajdova, J.; Sponerova, D.; Jonasova, A.; Cermak, J.; Michalova, K.

Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies

[rok vydání 2011, impact factor 2.764 ]

[64]

Jonasova, A.; Cermak, J.; Vondrakova, J.; Siskova, M.; Hochova, I.; Kadlckova, E.; Cerna, O.; Sykora, M.; Vozobulova, V.; Seifertova, N.; Michalova, K.; Zemanova, Z.; Brezinova, J.; Belohlavkova, P.; Kostecka, A.; Neuwirtova, R.

Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1)

[rok vydání 2012, impact factor 2.764 ]

[65]

Bystricka, D.; Sarova, I.; Zemanova, Z.; Brezinova, J.; Lizcova, L.; Izakova, S.; Dostalova-Merkerova, M.; Krejcik, Z.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cerna, O.; Cermak, J.; Michalova, K.

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites

[rok vydání 2011, impact factor 2.764 ]

[66]

Fuchs, O.; Provaznikova, D.; Kocova, M.; Kostecka, A.; Cvekova, P.; Neuwirtova, R.; Kobylka, P.; Cermak, J.; Brezinova, J.; Schwarz, J.; Markova, J.; Salaj, P.; Klamova, H.; Maaloufova, J.; Lemez, P.; Novakova, L.; Benesova, K.

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin´s lymphoma

[rok vydání 2008, impact factor 2.749]

[67]

Šárová, I.; Březinová, J.; Zemanová, Z.; Gančarčíková, M.; Vydra, J.; Čermák, J.; Michalová, K.

Rearrangement of 11q13.2 region in two patients with acute myeloid leukemia

[rok vydání 2013, impact factor 2.692 ]

[68]

Cermak, J.; Jonasova, A.; Vondrakova, J.; Cervinek, L.; Belohlavkova, P.; Neuwirtova, R.

A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes

[rok vydání 2013, impact factor 2.692 ]

[69]

Zemanova, Z.; Michalova, K.; Buryova, H.; Brezinova, J.; Kostylkova, K.; Bystricka, D.; Novakova, M.; Sarova, I.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Krejcik, Z.; Dostalova Merkerova, M.; Dohnalova, A.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J.

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis

[rok vydání 2014, impact factor 2.692 ]

[70]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Horakova, Z.; Campr, V.; Brezinova, J.; Zemanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome

[rok vydání 2017, impact factor 2.595 ]

[71]

Babicka, L.; Ransdorfova, S.; Brezinova, J.; Zemanova, Z.; Sindelarova, L.; Siskova, M.; Maaloufova, J.; Cermak, J.; Michalova, K.

Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH

[rok vydání 2007, impact factor 2.561]

[72]

Vasikova, A.; Belickova, M.; Budinska, E.; Cermak, J.

A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome

[rok vydání 2010, impact factor 2.555]

[73]

Jonasova, A.; Bokorova, R.; Polak, J.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Sponerova, D.; Cermak, J.; Mikulenkova, D.; Cervinek, L.; Brezinova, J.; Michalova, K.; Fuchs, O.

High level of full length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[74]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[75]

Šárová, I.; Březinová, J.; Zemanová, Z.; Ransdorfová, Š.; Izáková, S.; Svobodová, K.; Pavlištová, L.; Berková, A.; Čermák, J.; Jonášová, A.; Šišková, M.; Michalová, K.

Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia

[rok vydání 2015, impact factor 2.501 ]

[76]

Svobodova, K.; Zemanova, Z.; Lhotska, H.; Podskalska, L.; Belickova, M.; Brezinova, J.; Sarova, I.; Izakova, S.; Lizcova, L.; Berkova, A.; Siskova, M.; Jonasova, A.; Cermak, J.; Michalova, K.

Copy number neutral loss of heterozygosity (CN-LOH) 17p and homozygous mutations of TP53 gene are associated with complex chromosomal aberrations (CCA) in newly diagnosed myelodysplastic syndromes (MDS)

[rok vydání 2015, impact factor 2.501 ]

[77]

Májek, P.; Reicheltová, Z.; Suttnar, J.; Čermák, J.; Dyr, J.E.

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome

[rok vydání 2012, impact factor 2.420 ]

[78]

Marinov, I.; Kohoutová, M.; Tkáčová, V.; Pešek, A.; Čermák, J.; Cetkovský, P.

Clinical relevance of CD157 for rapid and cost-effective simultaneous evaluation of PNH granulocytes and monocytes by flow cytometry

[rok vydání 2014, impact factor 2.401 ]

[79]

Majek, P.; Pecankova, K.; Cermak, J.; Gasova, Z.; Dyr, J.E.

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups

[rok vydání 2015, impact factor 2.401 ]

[80]

Neuwirtova, R.; Fuchs, O.; Holicka, M.; Vostry, M.; Kostecka, A.; Hajkova, H.; Jonasova, A.; Cermak, J.; Cmejla, R.; Pospisilova, D.; Belickova, M.; Siskova, M.; Hochova, I.; Vondrakova, J.; Sponerova, D.; Kadlckova, E.; Novakova, L.; Brezinova, J.; Michalova, K.

Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia

[rok vydání 2012, impact factor 2.396 ]